Voyageur Pharmaceuticals Ltd VYYRF

Primary Symbol: V.VM

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Not a wave breaking the surface

<< Previous

Bullboard Posts

Next >>

Comment by postie1on Feb 22, 2024 10:39am

93 Views

Post# 35893198

RE:RE:Not a wave breaking the surface

Maybe a reread of that news release is needed and probably get someone to explain it. Only Jan. 16th, 2024 was written in stone.

For those interested in factual news the shorts are down to 24,822 as of Jan.15th and personaaly speaking for myself if I were that sure Ch. 11 was a done deal , I think one should have the nerve to short it a millon or 2. That is my opinion.
Another fact, Chapter 11 is American, Last I checked VM is Canadian.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments